Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 20/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3370809 | 0.98 | GSK3B (0.47) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL3369881 | 0.86 | GSK3B (0.42) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL3364467 | 0.84 | GSK3B (0.42) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL3364472 | 0.83 | GSK3B (0.43) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL3366174 | 0.82 | GSK3B (0.43) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL3364868 | 0.82 | GSK3B (0.43) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL3366183 | 0.82 | GSK3B (0.51) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL3367413 | 0.81 | GSK3B (0.47) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL3364483 | 0.81 | GSK3B (0.43) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL3366617 | 0.81 | GSK3B (0.43) | GSK3BCYP2D6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1603915-B1 | SUBSTITUTED 8 -PYRIDINYL-DIHYDROSPIRO- CYCLOALKYL -PYRIMIDO 1,2-a PYRIMIDIN-6-ONE AND 8 -PYRIMIDIN YL-DIHYDROSPIRO- CYCLOALKYL -PYRIMIDO 1,2-a PYRIMIDIN-6-ONE DERIVATIVES AND THEIR USE AGAINST NEUROGENERATIVE DISEASES | SANOFI AVENTIS (FR) | 2010-05-26 | — | — | EP | claimed |